Skip Ribbon Commands
Skip to main content
A- A A+

Clinical Trials

Completed:

  1. Chinese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES) Study  
  2. Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of Leuco-methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease  
  3. Randomized, double-blind, parallel-group, placebo controlled study of Lu AE58054 in patients with mild-moderate Alzheimer’s disease treated with an acetylcholinesterase inhibitor; Phase 3  
  4. A multicenter, double-blind, placebo-controlled, randomized, parallel-group phase 3 Study to Evaluate the Safety and Efficacy of Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Ongoing:

  1. Chinese Medicine Neuroaid Efficacy on Stroke recovery Extenstion (CHIMES-E) Study  
  2. NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects (NEURITES)  
  3. An Open-Label. Extension Study of the Effects of Leuco-methylthioninium bis(hydromethanesulfonate) in Subjects with Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia  
  4. A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer's disease" RVT-101-3001  
  5. The Alzheimer’s disease THErapy with NEuroaid (ATHENE) Study : Assessing the Safety and Efficacy of Neuroaid II (MLC901) in patients with mild to moderate Alzheimer's disease stable on Cholinesterase inhibitors or Memantine: A Randomized, double blind, placebo controlled trial